| Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis I Bighelli, A Rodolico, H García-Mieres, G Pitschel-Walz, WP Hansen, ... The Lancet Psychiatry 8 (11), 969-980, 2021 | 214 | 2021 |
| Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia S Leucht, A Crippa, S Siafis, MX Patel, N Orsini, JM Davis American Journal of Psychiatry 177 (4), 342-353, 2020 | 205 | 2020 |
| Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and … J Schneider-Thoma, K Chalkou, C Dörries, I Bighelli, A Ceraso, M Huhn, ... The lancet 399 (10327), 824-836, 2022 | 178 | 2022 |
| Antipsychotic drugs: from receptor-binding profiles to metabolic side effects S Siafis, D Tzachanis, M Samara, G Papazisis Current neuropharmacology 16 (8), 1210-1223, 2018 | 170 | 2018 |
| Maintenance treatment with antipsychotic drugs for schizophrenia A Ceraso, JJ Lin, J Schneider-Thoma, S Siafis, M Tardy, K Komossa, ... The Cochrane database of systematic reviews 2020 (8), 2020 | 167 | 2020 |
| The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population : A Systematic Review and Dose-Response Meta-analysis G Salanti, P Natalie, T Tonia, A Holloway, IR White, L Darwish, N Low, ... Ann Intern Med, 2022 | 108 | 2022 |
| Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review E Wagner, S Siafis, P Fernando, P Falkai, WG Honer, A Röh, D Siskind, ... Translational psychiatry 11 (1), 487, 2021 | 95 | 2021 |
| Antipsychotic-induced weight gain: dose-response meta-analysis of randomized controlled trials H Wu, S Siafis, T Hamza, J Schneider-Thoma, JM Davis, G Salanti, ... Schizophrenia bulletin 48 (3), 643-654, 2022 | 75 | 2022 |
| Family interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis A Rodolico, I Bighelli, C Avanzato, C Concerto, P Cutrufelli, L Mineo, ... The Lancet Psychiatry 9 (3), 211-221, 2022 | 73 | 2022 |
| Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis S Siafis, O Çıray, H Wu, J Schneider-Thoma, I Bighelli, M Krause, ... Molecular autism 13 (1), 10, 2022 | 69 | 2022 |
| Examination of dosing of antipsychotic drugs for relapse prevention in patients with stable schizophrenia: a meta-analysis S Leucht, S Bauer, S Siafis, T Hamza, H Wu, J Schneider-Thoma, ... JAMA psychiatry 78 (11), 1238-1248, 2021 | 63 | 2021 |
| Prevalence of cannabis use among medical students: A systematic review and meta-analysis G Papazisis, S Siafis, I Tsakiridis, I Koulas, T Dagklis, D Kouvelas Substance abuse: research and treatment 12, 1178221818805977, 2018 | 57 | 2018 |
| Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis S Siafis, O Çıray, J Schneider-Thoma, I Bighelli, M Krause, A Rodolico, ... Molecular autism 11, 1-19, 2020 | 46 | 2020 |
| Nonmedical use of prescription drugs among medical students and the relationship with illicit drug, tobacco, and alcohol use G Papazisis, I Tsakiridis, S Siafis Substance abuse: research and treatment 12, 1178221818802298, 2018 | 44 | 2018 |
| Metabolic side effects in persons with schizophrenia during mid‐to long‐term treatment with antipsychotics: a network meta‐analysis of randomized controlled trials A Burschinski, J Schneider‐Thoma, V Chiocchia, K Schestag, D Wang, ... World Psychiatry 22 (1), 116-128, 2023 | 41 | 2023 |
| Second-to-fourth digit ratio (2D: 4D) in psychiatric disorders: A systematic review of case-control studies L Fusar-Poli, A Rodolico, S Sturiale, B Carotenuto, A Natale, D Arillotta, ... Clinical Psychopharmacology and Neuroscience 19 (1), 26, 2021 | 39 | 2021 |
| Detecting a potential safety signal of antidepressants and type 2 diabetes: a pharmacovigilance‐pharmacodynamic study S Siafis, G Papazisis British journal of clinical pharmacology 84 (10), 2405-2414, 2018 | 39 | 2018 |
| Prolactin levels influenced by antipsychotic drugs in schizophrenia: A systematic review and network meta-analysis Y Zhu, C Zhang, S Siafis, K Zhuo, D Zhu, H Wu, D Liu, K Jiang, J Wang, ... Schizophrenia research 237, 20-25, 2021 | 36 | 2021 |
| A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders CM Diaz-Caneja, MW State, RJ Hagerman, S Jacquemont, O Marin, ... European Neuropsychopharmacology 48, 49-88, 2021 | 34 | 2021 |
| Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models E Stamoula, S Siafis, I Dardalas, A Ainatzoglou, A Matsas, T Athanasiadis, ... Frontiers in Immunology 12, 677879, 2021 | 32 | 2021 |
Stefan LeuchtProf. Dr. med., Klinik für Psychiatrie und Psychotherapie der TU-MünchenBestätigte E-Mail-Adresse bei lrz.tum.de
